Search
Search filters
Type
Audience
Category
Issue
Last updated
- 20231 results available
- 20222 results available
- 20218 results available
- 20191 results available
- 20162 results available
- 20141 results available
- 20124 results available
- 20092 results available
- 20074 results available
- 20065 results available
- 20057 results available
- 20044 results available
- 20032 results available
- 20025 results available
- 20011 results available
Displaying 31 - 45 of 49 items.
Archived - Important Safety Concerns re Use of Propofol for Sedation in Pediatric Patients
AlertHealth professional risk communication | 2001-05-01
Safety information regarding topical anesthetics and serious adverse events - For Health Professionals
AlertHealth professional risk communication | 2009-03-05
Archived - Association of CRESTOR
AlertHealth professional risk communication | 2005-03-08
Archived – Important Safety Information Regarding Casodex 150 mg – Accelerated Deaths in Localized Prostate Cancer Patients – For the Public
AlertHealth professional risk communication | 2003-08-26
Xylocaine (lidocaine HCl)
AlertHealth professional risk communication | 2006-12-06
Health Canada update on the tamoxifen shortage
AlertInformation update | 2019-11-20
FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely Elevated Estradiol Levels
AlertHealth professional risk communication | 2016-10-18
Important Safety Information Regarding Reports of Serious Hepatic Events in Patients Receiving ACCOLATE® (Zafirlukast) – For Health Professionals
AlertHealth professional risk communication | 2004-04-19
Archived – Updated safety information regarding Crestor
AlertPublic advisory | 2004-11-24
Archived - Accelerated deaths using Casodex® (bicalutamide) 150 mg in patients with localized prostate cancer
AlertHealth professional risk communication | 2003-08-26
SGLT2 Inhibitors [INVOKANA (canagliflozin), FORXIGA (dapagliflozin), XIGDUO (dapagliflozin/metformin), JARDIANCE (empagliflozin)] - Risk of Diabetic Ketoacidosis
AlertHealth professional risk communication | 2016-05-16
Archive - Safety Information about a Class of Asthma Drugs Known as Long-Acting Beta-2 Agonists
AlertPublic advisory | 2005-10-04
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
AlertHealth professional risk communication | 2022-04-14
Health Canada puts measures in place for medically necessary products affected by import restriction from 3 facilities in India
AlertInformation update | 2014-10-17
Archived - Health Canada reviewing new safety information on cardiac events in patients taking Losec (omeprazole) or Nexium (esomeprazole)
AlertInformation update | 2007-08-09